Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study
Legacy MEDSearch
MARCH 13, 2023
Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and effectiveness of the Vivasure PerQseal ® Closure Device System. and Europe.
Let's personalize your content